Idelalisib
Overview
Idelalisib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2216870).
API suppliers (2)
Suppliers of Idelalisib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 2 hold a GMP certificate on record in the EU or UK registers
- Natco PharmaIndia1 active DMF GMP on record
- Lupin LimitedIndia GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (4 approved US products), the latest listed US patent on Idelalisib expires 2 Sept 2033. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
- Canonical SMILES
- CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
- InChIKey
- IFSDAJWBUCMOAH-HNNXBMFYSA-N
Do you supply Idelalisib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.